Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Newbridge Financial Services Group Inc.

Newbridge Financial Services Group Inc. decreased its stake in Teladoc Health, Inc. (NYSE:TDOC) by 40.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,602 shares of the health services provider’s stock after selling 3,088 shares during the period. Newbridge Financial Services Group Inc.’s holdings in Teladoc Health were worth $42,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Point72 Asset Management L.P. boosted its holdings in shares of Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after buying an additional 3,063,172 shares in the last quarter. Geode Capital Management LLC raised its position in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Teladoc Health in the 3rd quarter valued at $15,801,000. Connor Clark & Lunn Investment Management Ltd. raised its position in Teladoc Health by 15.5% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after purchasing an additional 228,004 shares during the last quarter. Finally, Invenomic Capital Management LP raised its position in Teladoc Health by 155.2% in the 3rd quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock valued at $13,534,000 after purchasing an additional 896,552 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on TDOC shares. Royal Bank of Canada upped their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. The Goldman Sachs Group started coverage on shares of Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 price target for the company. Barclays upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Finally, TD Cowen cut their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $11.97.

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.95% of the company’s stock.

Teladoc Health Stock Performance

NYSE:TDOC opened at $12.99 on Wednesday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $21.74. The stock has a market cap of $2.24 billion, a PE ratio of -2.25 and a beta of 1.04. The firm’s fifty day simple moving average is $10.13 and its 200-day simple moving average is $9.20.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.